Press

Intervacc AB (publ) announces that the company has started the first phase of clinical safety studies in horses in the United States as part of the approval process for Strangvac^® in the U.S.

Intervacc AB (publ) announces today that the five-year distribution agreement signed in April 2021 with its partner Dechra Pharmaceuticals PLC has been extended by two years. The extension will take effect in April ... Read more

The animal health group Intervacc AB (publ) has appointed Anna-Carin Lagerlöf to the newly established role as Sales and Marketing Director. In this position, Anna-Carin will lead the company’s continued sales growth, ... Read more

Intervacc AB (publ) announces today that its European distribution partner, Dechra Pharmaceuticals PLC (“Dechra”), is launching Strangvac^® in Spain, Portugal and Slovenia. Vials of the vaccine against the ... Read more